We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cardinal Health (CAH) Stock Moves -1.64%: What You Should Know
Read MoreHide Full Article
In the latest trading session, Cardinal Health (CAH - Free Report) closed at $222.04, marking a -1.64% move from the previous day. Elsewhere, the Dow lost 0.36%, while the tech-heavy Nasdaq added 0.45%.
Coming into today, shares of the prescription drug distributor had lost 2.85% in the past month. In that same time, the Medical sector lost 3.65%, while the S&P 500 gained 1.27%.
Analysts and investors alike will be keeping a close eye on the performance of Cardinal Health in its upcoming earnings disclosure. The company is expected to report EPS of $2.92, up 14.51% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $66.96 billion, up 4.6% from the prior-year quarter.
For the full year, the Zacks Consensus Estimates are projecting earnings of $12.55 per share and revenue of $266.02 billion, which would represent changes of +11.46% and +4.63%, respectively, from the prior year.
Any recent changes to analyst estimates for Cardinal Health should also be noted by investors. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. Cardinal Health is currently a Zacks Rank #3 (Hold).
Looking at valuation, Cardinal Health is presently trading at a Forward P/E ratio of 17.99. This expresses a premium compared to the average Forward P/E of 16.97 of its industry.
Investors should also note that CAH has a PEG ratio of 1.36 right now. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. Medical - Dental Supplies stocks are, on average, holding a PEG ratio of 1.91 based on yesterday's closing prices.
The Medical - Dental Supplies industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 106, positioning it in the top 44% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Cardinal Health (CAH) Stock Moves -1.64%: What You Should Know
In the latest trading session, Cardinal Health (CAH - Free Report) closed at $222.04, marking a -1.64% move from the previous day. Elsewhere, the Dow lost 0.36%, while the tech-heavy Nasdaq added 0.45%.
Coming into today, shares of the prescription drug distributor had lost 2.85% in the past month. In that same time, the Medical sector lost 3.65%, while the S&P 500 gained 1.27%.
Analysts and investors alike will be keeping a close eye on the performance of Cardinal Health in its upcoming earnings disclosure. The company is expected to report EPS of $2.92, up 14.51% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $66.96 billion, up 4.6% from the prior-year quarter.
For the full year, the Zacks Consensus Estimates are projecting earnings of $12.55 per share and revenue of $266.02 billion, which would represent changes of +11.46% and +4.63%, respectively, from the prior year.
Any recent changes to analyst estimates for Cardinal Health should also be noted by investors. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. Cardinal Health is currently a Zacks Rank #3 (Hold).
Looking at valuation, Cardinal Health is presently trading at a Forward P/E ratio of 17.99. This expresses a premium compared to the average Forward P/E of 16.97 of its industry.
Investors should also note that CAH has a PEG ratio of 1.36 right now. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. Medical - Dental Supplies stocks are, on average, holding a PEG ratio of 1.91 based on yesterday's closing prices.
The Medical - Dental Supplies industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 106, positioning it in the top 44% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.